KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Prepaid Assets (2016 - 2025)

Astrazeneca (AZN) has 3 years of Prepaid Assets data on record, last reported at $2.0 billion in Q4 2025.

  • For Q4 2025, Prepaid Assets rose 17.1% year-over-year to $2.0 billion; the TTM value through Dec 2025 reached $2.0 billion, up 17.1%, while the annual FY2025 figure was $2.0 billion, 17.1% up from the prior year.
  • Prepaid Assets reached $2.0 billion in Q4 2025 per AZN's latest filing, up from $1.7 billion in the prior quarter.
  • Across five years, Prepaid Assets topped out at $2.0 billion in Q4 2025 and bottomed at $1.6 billion in Q4 2023.
  • Average Prepaid Assets over 3 years is $1.8 billion, with a median of $1.7 billion recorded in 2024.
  • Peak YoY movement for Prepaid Assets: rose 7.42% in 2024, then rose 17.1% in 2025.
  • A 3-year view of Prepaid Assets shows it stood at $1.6 billion in 2023, then rose by 7.42% to $1.7 billion in 2024, then increased by 17.1% to $2.0 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $2.0 billion in Q4 2025, $1.7 billion in Q4 2024, and $1.6 billion in Q4 2023.